AMEFLOR: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AMEFLOR
Largest movements
- Financial fixed assets +€13.4m
up €13.4m (+16.5%), from €81.2m to €94.6m
- Current investments -€9.8m
down €9.8m (-48.8%), from €20.1m to €10.3m
- Profit (loss) carried forward +€3.6m
up €3.6m (+28.9%), from €12.5m to €16.1m
- Financial income +€3.1m
up €3.1m (+416.4%), from €740,766 to €3.8m
- Taxes -€90,720
no longer reported in 2025 (was €90,720)
- Gross operating margin -€17,757
down €17,757 (-29.1%), from -€61,013 to -€78,769
- Other operating charges +€5,974
up €5,974 (+14.5%), from €41,294 to €47,269
- Financial charges -€3,011
down €3,011 (-12.6%), from €23,825 to €20,814
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €112,458,749 | €115,832,951 | +€3.4m | +3.0% |
| Fixed assets | 21/28 | €81,164,500 | €94,576,350 | +€13.4m | +16.5% |
| Financial fixed assets | 28 | €81,164,500 | €94,576,350 | +€13.4m | +16.5% |
| Current assets | 29/58 | €31,294,250 | €21,256,601 | -€10.0m | -32.1% |
| Amounts receivable within one year | 40/41 | €9,368,969 | €9,276,280 | -€92,689 | -1.0% |
| Other amounts receivable | 41 | €9,368,969 | €9,276,280 | -€92,689 | -1.0% |
| Current investments | 50/53 | €20,090,563 | €10,285,522 | -€9.8m | -48.8% |
| Cash at bank and in hand | 54/58 | €1,748,471 | €1,694,799 | -€53,672 | -3.1% |
| Deferred charges and accrued income | 490/1 | €86,246 | - | -€86,246 | |
| Total equity and liabilities | 10/49 | €112,458,749 | €115,832,951 | +€3.4m | +3.0% |
| Equity | 10/15 | €15,784,928 | €19,399,168 | +€3.6m | +22.9% |
| Contributions | 10/11 | €3,000,000 | €3,000,000 | = | 0.0% |
| Capital | 10 | €3,000,000 | €3,000,000 | = | 0.0% |
| Issued capital | 100 | €3,000,000 | €3,000,000 | = | 0.0% |
| Reserves | 13 | €300,000 | €300,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €300,000 | €300,000 | = | 0.0% |
| Legal reserve | 130 | €300,000 | €300,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €12,484,928 | €16,099,168 | +€3.6m | +28.9% |
| Amounts payable | 17/49 | €96,673,821 | €96,433,783 | -€240,038 | -0.2% |
| Amounts payable within one year | 42/48 | €96,673,821 | €96,433,783 | -€240,038 | -0.2% |
| Other amounts payable | 47/48 | €96,673,821 | €96,433,783 | -€240,038 | -0.2% |
| Other operating charges | 640/8 | €41,294 | €47,269 | +€5,974 | +14.5% |
| Non-recurring operating charges | 66A | - | €19,149 | +€19,149 | |
| Gross operating margin | 9900 | -€61,013 | -€78,769 | -€17,757 | -29.1% |
| Operating profit (loss) | 9901 | -€102,307 | -€145,187 | -€42,880 | -41.9% |
| Financial income | 75/76B | €740,766 | €3,825,240 | +€3.1m | +416.4% |
| Recurring financial income | 75 | €740,766 | €3,825,240 | +€3.1m | +416.4% |
| Financial charges | 65/66B | €23,825 | €20,814 | -€3,011 | -12.6% |
| Recurring financial charges | 65 | €23,825 | €20,814 | -€3,011 | -12.6% |
| Profit (loss) for the period before taxes | 9903 | €614,634 | €3,659,240 | +€3.0m | +495.4% |
| Income taxes | 67/77 | €90,720 | - | -€90,720 | |
| Profit (loss) for the period | 9904 | €523,915 | €3,659,240 | +€3.1m | +598.4% |
| Profit (loss) for the period to be appropriated | 9905 | €523,915 | €3,659,240 | +€3.1m | +598.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.